Name of the Drug Mechanism of Dosage Indications Contraindications Adverse Reaction Nursing Alert

Action
Generic Name: Inhibits the action of ORAL: Prescription Ranitidine is Parenteral: Advise patient to
Ranitidine histamine at the H2 Treatment dose: 150 ranitidine is contraindicated for Central nervous avoid alcohol and
receptor site located mg orally 2 times a approved for patients known to system (CNS): foods that may cause
Brand Name: primarily in gastric day OR 300 mg multiple indications, have hypersensitivity Malaise, dizziness, an increase in GI
Zantac parietal cells, orally once a day including treatment to the drug or any of somnolence, irritation.
resulting in after the evening and prevention of the ingredients. insomnia, vertigo,
Classification inhibition of gastric meal or at bedtime ulcers of the stomach mental confusion, Use caution during
Therapeutic: acid secretion. Maintenance dose: and intestines and agitation, and aerobic exercise and
antiulcer agents Therapeutic Effects: 150 mg orally once a treatment of hallucinations. endurance
Healing and day at bedtime gastroesophageal conditioning because
Pharmacologic: prevention of ulcers. Duration of therapy: reflux disease. of an increased risk
histamine H2 Decreased symptoms 8 weeks (treatment); of cardiac
antagonists of gastroesophageal up to 1 year arrhythmias.
reflux. Decreased (maintenance) Terminate exercise if
secretion of gastric patient exhibits
acid. PARENTERAL: untoward symptoms
IM or IV (bolus or (chest pain, shortness
intermittent infusion) of breath, etc.), or
Injection: displays other
Usual dose: 50 mg criteria for exercise
IM or IV every 6 to 8 termination
hours
Maximum dose: 400
mg/day

Continuous IV
Infusion:
Usual rate: 6.25
mg/hour
 Name of the Drug Mechanism of Dosage Indications Contraindications Adverse Reaction Nursing Alert
Action
Generic Name: Inhibits tablet Short-term Ketorolac is CNS: drowsiness, Monitor signs of GI
Ketorolac prostaglandin 10mg management of pain contraindicated in abnormal thinking, bleeding, including
synthesis, producing (not to exceed 5 days patients with dizziness, euphoria, abdominal pain,
Brand Name: peripherally injectable solution total for all routes moderate or severe headache. Resp: vomiting blood,
Toradol, and mediated analgesia. 15mg/mL combined). renal impairment asthma, dyspnea. blood in stools, or
Biorolac Also has antipyretic 30mg/mL (serum creatinine CV: edema, pallor, black, tarry stools.
and anti- >160 µ mol/l) or in vasodilation. GI: GI Report these signs to
Classification inflammatory prefilled syringe patients at risk for BLEEDING, the physician
Therapeutic: properties. 15mg/mL renal failure due to abnormal taste, immediately.
nonsteroidal anti- Therapeutic Effects: 30mg/mL volume depletion or diarrhea, dry mouth, Assess blood
inflammatory agents, Decreased pain. 60mg/2mL dehydration. dyspepsia, GI pain, pressure (BP)
nonopioid analgesics Ketorolac is nausea. GU: oliguria, periodically and
contraindicated in renal toxicity, compare to normal
Pharmacologic: pregnancy, labour, urinary frequency. values. NSAIDs can
pyrrolizine delivery or lactation increase BP in
carboxylic acid certain patients.

Be alert for signs of

prolonged bleeding
time such as bleeding
gums, nosebleeds,
and unusual or
excessive bruising.
Report these signs to
the physician.
Name of the Drug Mechanism of Dosage Indications Contraindications Adverse Reaction Nursing Alert
Action
Name of the Drug Mechanism of Dosage Indications Contraindications Adverse Reaction Nursing Alert
Action